Nucleic Acid Targets and Therapeutics (I-W5)

Chairs: Sidney Altman
  Valentin Vlassov

July 11, 2013

08.30 – 09.10

Marvin H. Caruthers   University of Colorado, Boulder, USA

Oligonucleotide synthesis interfaced with molecular biology

09.10 – 09.35

Zhang Li-He   School of Pharmaceutical Sciences; State Key Laboratories of Natural and Biomimetic Drugs, Peking University, Beijing, China

Synthesis and properties of isonucleoside modified oligonucleotides and siRNAs

09.35 – 10.00

Marina Zenkova   ICBFM SB RAS, Russia

Anticancer siRNAs

10.00 – 10.25

Andrzej Dziembowski   Department of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, Poland

The role of the Dis3 exonuclease in cell physiology and multiple myeloma

10.25 – 10.40

Marina Gottikh   Lomonosov Moscow State University, Moscow, Russia

Modified oligonucleotides as inhibitors of HIV-1 enzymes

10.40 – 10.55

Julian A. Tanner  University of Hong Kong

Nucleic acid aptamers against Plasmodium lactate dehydrogenase for malaria diagnosis – discovery, characterization, structure and application